400720-77-6 Usage
General Description
(6-amino-pyridin-3-ylmethyl)-carbamic acid tert-butyl ester is a chemical compound that is commonly used in the synthesis of pharmaceuticals and agrochemicals. It is a tert-butyl ester of carbamic acid, which is derived from 6-amino-pyridin-3-ylmethyl. The compound is used as an intermediate in the production of various drugs and agricultural chemicals due to its ability to modify the activity of enzymes and receptors in biological systems. It is also used as a building block for the synthesis of heterocyclic compounds, which are widely used in the pharmaceutical industry. Additionally, it has applications in the development of new materials and in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 400720-77-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,0,7,2 and 0 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 400720-77:
(8*4)+(7*0)+(6*0)+(5*7)+(4*2)+(3*0)+(2*7)+(1*7)=96
96 % 10 = 6
So 400720-77-6 is a valid CAS Registry Number.
400720-77-6Relevant articles and documents
METTL3 INHIBITORY COMPOUNDS
-
Paragraph 00983; 00987-00989, (2020/10/20)
The present invention relates to compounds of formula (I) that function as inhibitors of METTL3 (N6-adenosine-methyltransferase 70 kDa subunit) enzyme activity: X-Y-Z5 (I) wherein X, Y and Z are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, and autoimmune diseases, as well as other diseases or conditions in which METTL3 activity 10 is implicated.
AMINOPYRIDINE DERIVATIVES
-
Page/Page column 74, (2009/12/05)
The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (such as asthma or COPD); and methods of treating patients with such compounds; wherein R1 - R11 ar
